These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 25733956)
1. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Leuchter AF; Hunter AM; Krantz DE; Cook IA Dialogues Clin Neurosci; 2014 Dec; 16(4):525-37. PubMed ID: 25733956 [TBL] [Abstract][Full Text] [Related]
2. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Leuchter AF; Hunter AM; Krantz DE; Cook IA Ann N Y Acad Sci; 2015 May; 1344(1):78-91. PubMed ID: 25809789 [TBL] [Abstract][Full Text] [Related]
3. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Leuchter AF; Cook IA; Hunter A; Korb A Clin EEG Neurosci; 2009 Apr; 40(2):78-83. PubMed ID: 19534301 [TBL] [Abstract][Full Text] [Related]
4. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226 [TBL] [Abstract][Full Text] [Related]
5. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Caudill MM; Hunter AM; Cook IA; Leuchter AF Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429 [TBL] [Abstract][Full Text] [Related]
6. Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies. Thase ME Dialogues Clin Neurosci; 2014 Dec; 16(4):539-44. PubMed ID: 25733957 [TBL] [Abstract][Full Text] [Related]
7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207 [TBL] [Abstract][Full Text] [Related]
8. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. Trivedi MH; Lin EH; Katon WJ CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951 [TBL] [Abstract][Full Text] [Related]
9. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls. Liu Y; Yieh L; Yang T; Drinkenburg W; Peeters P; Steckler T; Narayan VA; Wittenberg G; Ye J BMC Genomics; 2016 Aug; 17(1):669. PubMed ID: 27549765 [TBL] [Abstract][Full Text] [Related]
10. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Hunter AM; Cook IA; Leuchter AF Psychiatr Clin North Am; 2007 Mar; 30(1):105-24. PubMed ID: 17362807 [TBL] [Abstract][Full Text] [Related]
11. Gene × environment interactions in the prediction of response to antidepressant treatment. Klengel T; Binder EB Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target. Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331 [TBL] [Abstract][Full Text] [Related]
13. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344 [TBL] [Abstract][Full Text] [Related]
14. Protein Biomarkers in Major Depressive Disorder: An Update. Woods AG; Wormwood KL; Iosifescu DV; Murrough J; Darie CC Adv Exp Med Biol; 2019; 1140():585-600. PubMed ID: 31347073 [TBL] [Abstract][Full Text] [Related]
15. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder. Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613 [TBL] [Abstract][Full Text] [Related]